WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT06967805 · RECRUITING

Trial details

NCT number: NCT06967805
Sponsor: Mediar Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2025-05-05
Primary completion: 2027-08-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.